Blue Water Life Science Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Hold |
724,014
| – | – | 11.2% | 4 |
|
|
2025
Q1 | $12.9M | Buy |
724,014
+120,014
| +20% | +$2.13M | 12.73% | 4 |
|
|
2024
Q4 | $12.9M | Hold |
604,000
| – | – | 11.45% | 3 |
|
|
2024
Q3 | $18.9M | Buy |
604,000
+94,000
| +18% | +$2.94M | 16.59% | 2 |
|
|
2024
Q2 | $7.92M | Buy |
+510,000
| New | +$7.92M | 7.7% | 4 |
|
|
2022
Q3 | – | Sell |
-275,551
| Closed | -$5.92M | – | 11 |
|
|
2022
Q2 | $5.92M | Sell |
275,551
-748,964
| -73% | -$16.1M | 3.21% | 8 |
|
|
2022
Q1 | $37.9M | Buy |
1,024,515
+179,545
| +21% | +$6.64M | 17.99% | 3 |
|
|
2021
Q4 | $38.4M | Sell |
844,970
-75,521
| -8% | -$3.43M | 11.76% | 4 |
|
|
2021
Q3 | $58.3M | Buy |
920,491
+399,975
| +77% | +$25.3M | 18.98% | 2 |
|
|
2021
Q2 | $47.6M | Buy |
520,516
+29,000
| +6% | +$2.65M | 17.93% | 2 |
|
|
2021
Q1 | $33.5M | Buy |
491,516
+64,016
| +15% | +$4.36M | 16.35% | 2 |
|
|
2020
Q4 | $31M | Buy |
+427,500
| New | +$31M | 18.18% | 1 |
|